Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-24

Clinical Trial Update: Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating hyaluronic acid–containing artificial tears for post-cataract surgery-related dry eye disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid–containing artificial tears (hyaluronic acid-containing artificial tears)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Dry Eye Disease, Cataract | Phase 4 | Status: COMPLETED